MY145649A - Methods for refolding of recombinant antibodies - Google Patents

Methods for refolding of recombinant antibodies

Info

Publication number
MY145649A
MY145649A MYPI20070610A MYPI20070610A MY145649A MY 145649 A MY145649 A MY 145649A MY PI20070610 A MYPI20070610 A MY PI20070610A MY PI20070610 A MYPI20070610 A MY PI20070610A MY 145649 A MY145649 A MY 145649A
Authority
MY
Malaysia
Prior art keywords
methods
refolding
recombinant antibodies
igg proteins
enrichment
Prior art date
Application number
MYPI20070610A
Inventor
Thomas Dillon
Douglas Rehder
Pavel Bondarenko
Margaret Ricci
Himanshu S Gadgil
Douglas Banks
Joe Zhou
Yuefeng Lu
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Priority to MYPI20070610A priority Critical patent/MY145649A/en
Publication of MY145649A publication Critical patent/MY145649A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

THE PRESENT INVENTION IS GENERALLY DIRECTED TO METHODS OF PRODUCING AN INCREASE IN THE ENRICHMENT OR RECOVERY OF PREFERRED FORMS OF IGG PROTEINS. MORE PARTICULARLY, THE INVENTION RELATES TO SUBJECTING PREPARATIONS OF SUCH RECOMBINANT IGG PROTEINS WITH A REDUCTION/OXIDATION COUPLING REAGENT AND OPTIONALLY A CHAOTROPIC AGENT.
MYPI20070610A 2007-04-19 2007-04-19 Methods for refolding of recombinant antibodies MY145649A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20070610A MY145649A (en) 2007-04-19 2007-04-19 Methods for refolding of recombinant antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20070610A MY145649A (en) 2007-04-19 2007-04-19 Methods for refolding of recombinant antibodies

Publications (1)

Publication Number Publication Date
MY145649A true MY145649A (en) 2012-03-15

Family

ID=48040493

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20070610A MY145649A (en) 2007-04-19 2007-04-19 Methods for refolding of recombinant antibodies

Country Status (1)

Country Link
MY (1) MY145649A (en)

Similar Documents

Publication Publication Date Title
SG156672A1 (en) Methods for refolding of recombinant antibodies
WO2009036209A3 (en) Homogeneous antibody populations
EP2270045B8 (en) Antibodies against Clostridium difficile toxins and uses thereof
WO2009155324A3 (en) Pigf-1 assay and kits and components thereof
SG162834A1 (en) Refolding of recombinant proteins
WO2007001264A3 (en) Method of making recombinant human antibodies for use in biosensor technology
MY150242A (en) Antigen binding proteins capable of binding thymic stromal lymphopoietin
NZ601923A (en) High Affinity Human Antibodies to PCSK9
CY1112342T1 (en) CHEMICAL, HYBRID AND SUCCESSFUL POLYPTIPES OF MINING COOK NW1870
WO2008076560A3 (en) Human monoclonal antibodies to btla and methods of use
TN2011000433A1 (en) Alpha -4-beta-7heterodimer specific antagonist antibody
WO2011022077A3 (en) A nucleic acid cassette for producing recombinant antibodies
WO2012054929A3 (en) Use of human serum albumin to decrease antigenicity of therapeutic proteins
MX2010001237A (en) Novel antibodies.
WO2008098917A3 (en) Novel antibodies against igf-ir
WO2008085962A3 (en) Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
WO2004035742A3 (en) Sets of digital antibodies directed against short epitopes, and methods using same
WO2011152694A8 (en) Fusion protein having factor vii activity
TW200801202A (en) Alpha-enolase specific antibody and method of use
WO2008090290A3 (en) Chemically defined synthetic culture medium
MX2009008754A (en) Novel antibodies against igf-ir.
WO2006058359A3 (en) Protein allergen derivatives
WO2008054431A3 (en) Anti-hyperproliferative therapies targeting hdgf
WO2011015379A8 (en) Human hcv-interacting proteins and methods of use
WO2008082439A3 (en) Antigen specific nanoparticles